Blood Disorders: More Than Just a Diagnosis – Malaika Mehboob
Malaika Mehboob, Student Ambassador of Physiogic, shared on LinkedIn:
”Blood Disorders: More Than Just a Diagnosis
Blood disorders encompass a wide spectrum of conditions affecting red blood cells, white blood cells, platelets, and clotting factors.
From anemia, which impairs oxygen delivery, to hemophilia and clotting disorders that disrupt normal hemostasis, each condition reflects a unique pathophysiological mechanism.
Genetic disorders like sickle cell disease and thalassemia highlight how molecular changes in hemoglobin can significantly impact quality of life, while conditions such as leukemia and autoimmune blood diseases demonstrate the complex interplay between the immune system and hematopoiesis.
Polycythemia and platelet deficiencies further remind us how imbalance, whether excess or deficiency, can lead to serious clinical consequences.
Early diagnosis, evidence-based management, and patient education remain critical in improving outcomes.
As healthcare professionals and students, understanding these disorders at a cellular and clinical level is essential for delivering holistic and compassionate care.
Continuous learning in hematology isn’t optional; it’s vital.”
Stay updated with Hemostasis Today.
-
Apr 15, 2026, 04:52Ulrich Pecks: Personalized Approaches to VTE Prevention in Pregnant Women with Inherited Thrombophilia
-
Apr 15, 2026, 04:06Brenda Pleasant: Insights from the HFA Symposium on Hemophilia Care
-
Apr 15, 2026, 03:43Lexy Halloran: Addressing Diagnostic Inequities in Women with Chronic Conditions
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids